featured
SGLT2 Inhibitors Influence Skeletal Muscle Pathology in Patients With HFrEF
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
European Journal of Heart Failure
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Sodium-glucose cotransporter 2 inhibitors influence skeletal muscle pathology in patients with heart failure and reduced ejection fraction
Eur. J. Heart Fail 2024 Mar 11;[EPub Ahead of Print], N Wood, S Straw, CW Cheng, Y Hirata, MG Pereira, H Gallagher, S Egginton, W Ogawa, SB Wheatcroft, KK Witte, LD Roberts, TS BowenFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.